Pharmacokinetics of experimental pentavalent antimony after intramuscular administration in adult volunteers
Authors:
- 1 May 2006
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 67 (3) , 193-203
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Leishmaniasis– current chemotherapy and recent advances in the search for novel drugsTrends in Parasitology, 2003
- Current treatment approaches to leishmaniasisCurrent Opinion in Infectious Diseases, 2003
- High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controlsMemórias do Instituto Oswaldo Cruz, 2003
- Fluconazole for the Treatment of Cutaneous Leishmaniasis Caused byLeishmania majorNew England Journal of Medicine, 2002
- On-line determination of antimony(III) and antimony(V) in liver tissue and whole blood by flow injection – hydride generation – atomic absorption spectrometryTalanta, 2001
- Glutathione-Induced Conversion of Pentavalent Antimony to Trivalent Antimony in Meglumine AntimoniateAntimicrobial Agents and Chemotherapy, 2001
- In vitro antileishmanial properties of tri- and pentavalent antimonial preparationsAntimicrobial Agents and Chemotherapy, 1995
- Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasisResearch in Veterinary Science, 1995
- Metabolism and disposition of inorganic arsenic in laboratory animals and humansEnvironmental Geochemistry and Health, 1992
- RENAL CLEARANCE OF PENTAVALENT ANTIMONY (SODIUM STIBOGLUCONATE)The Lancet, 1980